Juvenile dermatomyositis in a 6 year old boy: A rare case
Keywords:
Juvenile Dermatomyositis, Vasculophaty disease, Rare disease, Systemic autoimmune diseaseAbstract
Juvenile Dermatomyositis (JDM) is a systemic capillary vasculopathy and idiophatic inflammatory myopathies (IIM) in children. It is a rare disease with incidence in the United States 3 per million children per year. A 6-year-old child complained about red spots on his right and left knees. He had red spots which became white spots and thickening skin on his knuckles since 4 months ago before hospitalized. Redness occurred around the eyes and his back since 2 months ago. He had muscle weakness especially on his limb since 2 months ago. JDM has peak occurrence during infancy with ages of 5 and 15. Genetic, environmental and immunological factors are believed to contribute to the development of JDM. The clinical symptoms of this condition are varied, with different levels of skin, muscle, gastrointestinal and cardiac. The goals of treatment are to control inflammatory myositis and prevent complication. It is important for dermatologist to know this disease clearly, so that can make a proper diagnosis and carry out appropriate management.References
Thompson C, Piguet V, Choy E. The pathogenesis of dermatomyositis. Br J Dermatol. 2018;179(6):1256-62.
Mainetti C, Terziroli Beretta-Piccoli B, Selmi C. Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review. Clin Rev Allergy Immunol. 2017;53(3):337-56.
DeWane ME, Waldman R, Lu J. Dermatomyositis: Clinical features and pathogenesis. J Am Acad Dermatol. 2020;82(2):267-81.
Wedderburn LR, Rider LG. Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Pract Res Clin Rheumatol. 2009;23(5):665-78.
Wu JQ, Lu MP, Reed AM. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment. World J Pediatr. 2020;31–43.
Wu Q, Wedderburn LR, McCann LJ. Juvenile dermatomyositis: Latest advances. Best Pract Res Clin Rheumatol. 2017;31(4):535-7.
Yang SH, Chang C, Lian ZX. Polymyositis and dermatomyositis-challenges in diagnosis and management. J Transl Autoimmun. 2019;2:100018.
Batthish M, Feldman BM. Juvenile dermatomyositis. Curr Rheumatol Rep. 2011;13(3):216-24.
Findlay AR, Goyal NA, Mozaffar T. An overview of polymyositis and dermatomyositis. Muscle Nerve. 2015;51(5):638-56.
Iaccarino L, Ghirardello A, Bettio S, Zen M, Gatto M, Punzi L, et al. The clinical features, diagnosis and classification of dermatomyositis. J Autoimmun. 2014;48-49:122-7.
Pachman LM, Nolan BE, DeRanieri D, Khojah AM. Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy. Curr Treatm Opt Rheumatol. 2021;7(1):39-62.
Muro Y, Sugiura K, Akiyama M. Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review. Clin Rev Allergy Immunol. 2016;51(3):293-302.
Enders FB, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, et al. Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis. 2017;76(2):329-40.
Chansky PB, Mittal L, Sunderkötter C, Werth VP. Dermatomyositis. In: Pigmented Ethnic Skin and Imported Dermatoses [Internet]. Cham: Springer International Publishing; 2018. p. 343-52. Available from: http://link.springer.com/10.1007/978-3-319-69422-1_31.
